Lunt M, Felsenberg D, Reeve J, Benevolenskaya L, Cannata J, Dequeker J, Dodenhof C, Falch J A, Masaryk P, Pols H A, Poor G, Reid D M, Scheidt-Nave C, Weber K, Varlow J, Kanis J A, O'Neill T W, Silman A J
Institute of Public Health, Cambridge, United Kingdom.
J Bone Miner Res. 1997 Nov;12(11):1883-94. doi: 10.1359/jbmr.1997.12.11.1883.
In Europe there is a 3-fold variation, according to geographical center, in risk of vertebral deformity in men and women over the age of 50. We investigated the relationship between bone density, as assessed by dual-energy X-ray absorptiometry (DEXA) of the spine and hip and prevalent vertebral deformities in 13 of the 36 centers participating in the European Vertebral Osteoporosis Study (EVOS). Each center recruited an age-stratified sample of men and women aged 50 years and over, and of those who agreed to densitometry, 288/2088 women and 233/1908 men were found to have one or more deformities of the vertebrae between T4 and L4 as assessed by the McCloskey algorithm. DEXA was in each case performed on L2-L4, the proximal femur, or both. Bone densitometry results were cross-calibrated between centers using the European Spine Phantom prototype and results expressed as bone mineral density (BMD, g/cm2). In both genders, subjects with deformities involving loss of anterior vertebral body height alone comprised over 20% of the total with deformities and these related poorly to BMD. Other classes of deformity were found by logistic regression to relate significantly to BMD in one or both genders, with odds ratios for the risk of any of these ranging from 1.67 to 2.11 for a 1 SD reduction in bone density at spine, femoral neck, or trochanter (p < 0.001). Adjusting for anthropometric variables and BMD did not remove the effect of age on risk which rose 1.67- to 1.78-fold per decade according to gender. The greater unadjusted rate of increase in deformity risk with age in women was attributable to their faster rate of bone loss with age; after adjusting for age, body mass index (BMI), and BMD at the trochanter in grams per square centimeter, men had a 2-fold higher risk of deformity than women. Analysis of the relationship between mean bone density and the prevalence of deformity in each center demonstrated no significant differences between centers in either gender, after adjusting for BMD, age, and BMI together with an a posteriori statistical adjustment for imperfect cross-calibration of densitometers. It is concluded that BMD is an important determinant of deformity risk in both genders. Together with age, BMD explains much of the differences in risk both between the sexes and between individual geographical centers in Europe.
在欧洲,50岁以上男性和女性椎体畸形风险根据地理中心存在3倍的差异。我们在参与欧洲椎体骨质疏松研究(EVOS)的36个中心中的13个中心,调查了通过脊柱和髋部双能X线吸收法(DEXA)评估的骨密度与椎体畸形患病率之间的关系。每个中心招募了年龄分层的50岁及以上男性和女性样本,在同意进行骨密度测定的人群中,通过麦克洛斯基算法评估发现,288/2088名女性和233/1908名男性在T4至L4之间存在一个或多个椎体畸形。DEXA在每种情况下均在L2-L4、股骨近端或两者上进行。各中心之间使用欧洲脊柱体模原型对骨密度测定结果进行交叉校准,并将结果表示为骨矿物质密度(BMD,g/cm²)。在男女两性中,仅涉及椎体前缘高度丢失的畸形患者占畸形总数的20%以上,且这些与BMD的相关性较差。通过逻辑回归发现,其他类型的畸形在男女中一种或两种性别中均与BMD显著相关,脊柱、股骨颈或大转子处骨密度每降低1个标准差,任何一种畸形风险的比值比范围为1.67至2.11(p<0.001)。调整人体测量变量和BMD并没有消除年龄对风险的影响,根据性别,年龄每增加十岁,风险上升1.67至1.78倍。女性未调整的畸形风险随年龄增长的速度更快,这归因于她们随年龄增长更快的骨质流失;在调整年龄、体重指数(BMI)和大转子处每平方厘米克数的BMD后,男性畸形风险比女性高2倍。分析每个中心平均骨密度与畸形患病率之间的关系表明,在调整BMD、年龄和BMI以及对骨密度仪不完全交叉校准进行事后统计调整后,男女两性各中心之间均无显著差异。得出的结论是,BMD是男女两性畸形风险的重要决定因素。与年龄一起,BMD解释了欧洲男女之间以及各个地理中心之间风险差异的很大一部分。